ストックスクリーナーアプリを入手
4.55
0.22%
0.010
前日終値:
$4.54
開ける：
$4.5
24時間の取引高:
541.54K
Relative Volume:
0.43
時価総額：
$124.75M
収益：
$160.43M
当期純損益:
$-227.64M
株価収益率:
-0.0662
EPS:
-68.77
ネットキャッシュフロー:
$-170.79M
1週間 パフォーマンス:
-4.41%
1か月 パフォーマンス:
-33.38%
6か月 パフォーマンス:
+29.63%
1年 パフォーマンス:
-0.66%
1日の値動き範囲:
$4.39
$4.64
1週間の範囲:
$4.06
$4.845
52週間の値動き範囲:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
AGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
4.55 | 144.66M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | 開始されました | Robert W. Baird | Outperform |
| 2023-02-28 | 再開されました | H.C. Wainwright | Buy |
| 2022-09-28 | 開始されました | SMBC Nikko | Outperform |
| 2021-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-04-22 | 開始されました | B. Riley FBR | Buy |
| 2016-10-28 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | 繰り返されました | Maxim Group | Buy |
| 2016-03-11 | アップグレード | Maxim Group | Hold → Buy |
| 2015-12-16 | 開始されました | Jefferies | Buy |
| 2015-10-27 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-07-27 | 繰り返されました | MLV & Co | Buy |
| 2015-06-11 | 開始されました | Oppenheimer | Outperform |
| 2015-01-12 | 繰り返されました | Maxim Group | Buy |
| 2015-01-09 | 繰り返されました | MLV & Co | Buy |
| 2015-01-09 | 繰り返されました | Maxim Group | Buy |
| 2014-12-19 | 繰り返されました | Maxim Group | Buy |
| 2014-05-08 | 繰り返されました | Maxim Group | Buy |
| 2014-03-14 | 繰り返されました | MLV & Co | Buy |
| 2013-10-08 | 繰り返されました | Maxim Group | Buy |
| 2012-01-05 | 開始されました | William Blair | Outperform |
| 2011-12-01 | 開始されました | Global Hunter Securities | Buy |
すべてを表示
Agenus Inc (AGEN) 最新ニュース
Agenus Inc. Matches Institutional Buying FilterPortfolio Gains Report & High Conviction Buy Zone Picks - sundaytimes.kr
Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
Agenus Inc. Reports Q2 2025 Financial Results - TipRanks
Agenus Inc. Faces Ongoing Risks: What Investors Need to Know - TipRanks
Technical analysis overview for Agenus Inc. stockEarnings Recap Summary & AI Driven Stock Price Forecasts - Newser
Will breakout in Agenus Inc. lead to full recovery2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Key metrics from Agenus Inc.’s quarterly dataMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034 - GlobeNewswire Inc.
Real time alert setup for Agenus Inc. performanceMarket Trend Review & Expert-Curated Trade Recommendations - Newser
Trapped Investors in Agenus Inc. Await Breakout SignalWatchlist for Low Risk High Return Stocks Updated - sundaytimes.kr
Agenus Inc Reports Q2 2025 Earnings: EPS Loss of $2.03, Revenue at $25.7 Million, Missing Estimates - GuruFocus
Is Agenus Inc. still worth holding after the dipRecession Risk & AI Optimized Trade Strategies - Newser
Agenus Faces Ongoing Risks Despite Stable Consensus - AInvest
Can Agenus Inc. disrupt its industryMultiplier Stock Alert - thegnnews.com
Agenus Inc. shares rise 2.29% after-hours following Q2 earnings report. - AInvest
Agenus: Cash Starved Pharma Counting On Bot/Bal Cancer Bounty (NASDAQ:AGEN) - Seeking Alpha
Agenus Inc (AGEN) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
Agenus 2025 Q2 Earnings Improved Losses Amid Strategic Momentum - AInvest
Agenus Inc. shares fall 3.75% premarket after reporting a $30 million loss in Q2 earnings. - AInvest
Agenus Inc. stock trendline breakdownAI Trend Detection for Entry Timing - Newser
Agenus stock price target lowered to $23 by H.C. Wainwright on higher expenses - Investing.com Canada
Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
Agenus: Q2 Earnings Snapshot - San Francisco Chronicle
Agenus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agenus Posts 48% Q2 Revenue Miss - AOL.com
Agenus Reports Q2 2025 Financials, Secures $91M, and Plans Phase 3 Trial for BOT/BAL Therapy. - AInvest
Agenus: A Contrarian Play on Immuno-Oncology's Next Frontier Amid Financial Reengineering - AInvest
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress - The Globe and Mail
Smart tools for monitoring Agenus Inc.’s price actionTrading Watchlist with Real Time Filters - Newser
Is Agenus Inc. exposed to currency risksHigh Profit Stock Recommendations - kangso.co.kr
Agenus Earnings Outlook: Analysts Expect $0.50 EPS in Q2 2025 - AInvest
Agenus (AGEN) Expected to Announce Earnings on Monday - Defense World
Agenus (NASDAQ:AGEN) Upgraded to Buy at Wall Street Zen - Defense World
Agenus AGEN Q2 2025 Earnings Preview Upside Potential on Strategic CDMO Shift - AInvest
Examining the Future: Agenus's Earnings Outlook - 富途牛牛
Should value investors consider Agenus Inc.ROI Enhanced Trading Plan - newsyoung.net
Why Agenus Inc. stock attracts strong analyst attentionInsider Strategy for High Conviction Picks - Newser
Tools to monitor Agenus Inc. recovery probabilityLong-Term Stock Growth Forecast Insights - Newser
Agenus Inc. shares fall 2.41% intraday after Delhi High Court restrains Zydus Lifesciences from launching nivolumab biosimilar. - AInvest
How many analysts rate Agenus Inc. as a “Buy”Build a portfolio that outperforms the market - Jammu Links News
What institutional investors are buying Agenus Inc. stockMaximize portfolio value with expert tips - Jammu Links News
Agenus Inc. Stock Analysis and ForecastMaximize returns with strategic portfolio planning - Jammu Links News
Is Agenus Inc. a growth stock or a value stockAchieve superior returns through strategic trading - Jammu Links News
What markets is RILYL expanding into Is Agenus Inc. stock a good long term investment optionConsistently high yield - Jammu Links News
Why is Agenus Inc. stock attracting strong analyst attentionExceptional trading results - Jammu Links News
What makes Agenus Inc. stock price move sharplyCapitalize on proven investment strategies - Jammu Links News
Should I hold or sell Agenus Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
What analysts say about Agenus Inc. stockMaximize returns with strategic trading plans - Jammu Links News
How strong is Agenus Inc. company’s balance sheetAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is Agenus Inc. a good long term investmentRapid wealth creation - Jammu Links News
Agenus Inc (AGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):